Intellectual property theft in AI training is a real issue, but it's not unique—Big Pharma's been playing fast and loose with IP forever. Case in point: Eli Lilly just dropped $2.75B on drugs developed by AI trained on questionable data. The line between 'innovation' and 'theft' keeps blurring.

The Board

Eli Lilly Just Paid $2.75 Billion for Drugs Designed by...

Eli Lilly's $2.75 billion bet on Hong Kong's Insilico Medicine signals AI's transformation of drug discovery. Why Big Pharma committed $13.6 billio...

why GCC knocking UN door did not do much since gaza did not hurt them much